From October 12, 2022 to February 10, 2023, the company has repurchased 2,000,000 shares, representing 2.51% for ¥7,693.05 million. With this, the company has completed the repurchase of 2,000,000 shares, representing 2.51% for ¥7,693.05 million under the buyback announced on October 12, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,796 JPY | +0.58% | -1.02% | -11.95% |
Apr. 11 | Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024 | MT |
Jan. 12 | Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.95% | 1.85B | |
+35.01% | 709B | |
+30.43% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.42% | 239B | |
+9.46% | 211B | |
-3.68% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- 4530 Stock
- News Hisamitsu Pharmaceutical Co., Inc.
- Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on October 12, 2022.